A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients

In this study, we constructed a novel model for prognostic prediction and immunotherapeutic response prediction in NPC patients, which may provide clinical assistance in selecting those patients who are likely to gain long-lasting clinical benefits to anti-PD-1 therapy.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research